# Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris

> **NCT06654817** · — · COMPLETED · sponsor: **Chao Ji** · enrollment: 38 (actual)

## Conditions studied

- Pemphigus
- Pemphigus Vulgaris (PV)

## Interventions

- **DRUG:** Ofatumumab subcutaneous injection

## Key facts

- **NCT ID:** NCT06654817
- **Lead sponsor:** Chao Ji
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-04-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06654817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06654817, "Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06654817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*